ABSTRACT
The widespread use of optical coherence tomography
(OCT) has changed the way ophthalmologists evalu-
ate and treat age-related macular degeneration
(AMD). OCT has been added to the armamentarium
of macular imaging that now includes color fundus
photography, fluorescein angiography (FA), and indo-
cyanine green angiography. Although each of these
modalities is important in the management of macular
degeneration, OCT provides useful information
regarding retinal structure. Cross-sectional imaging
with commercially available units gives an axial res-
olution of 10 to 15 mm, and ultrahigh resolution OCT
(UHR-OCT) provides 2-to 3-mm resolution. This data
can be used in the diagnosis and management of
AMD; reliance on OCT as part of the decision
making process in treatment with different anti-
vascular endothelial growth factor (VEGF) agents is
rapidly becoming standard of care.
